BusinessEarth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical PatentsBy Nasdaq OMXNov 14, 2017, 1:01 PM UTC
BusinessImmuron Successfully Completes NASH Phase II Clinical Study MilestoneBy Nasdaq OMXNov 9, 2017, 2:01 PM UTC
BusinessBlake Insomnia Therapeutics Inc. Announces Submitting Clinical Trial Application for Phase II Clinical TestingBy Nasdaq OMXAug 25, 2017, 1:30 PM UTC
